Anti-IL-12/IL-23 Antibody (Ustekinumab)
Catalog No.
F2115
Anti-IL-12/IL-23 Antibody (Ustekinumab)
Featured Products
Ustekinumab is a humanized monoclonal antibody that is primarily used to treat moderate to severe plaque psoriasis and psoriatic arthritis. It blocks the signaling pathways mediated by interleukin-12 (IL-12) and interleukin-23 (IL-23) by targeting and inhibiting the p40 subunits, thereby reducing inflammatory responses. Ustekinumab is derived from antibodies expressed in mammalian cells using recombinant DNA technology.
Dry ice
815610-63-0
-80°C
2 years
Liquid
1 mg/mL
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Stelara
100 mM Pro 20 mM Arg pH 5.0.
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
IL-12/IL-23
Please avoid freeze-thaw cycles.